DCLK1 and colorectal carcinoma: Considering that CSCs were critical for cancer initiation, progression, metastasis, relapse and therapy resistance,35 we found that DCLK1, a CSCs marker, weakened the sensitivity of CRC cells to 5‐fluorouracil.